17.5 mg tirzepatide Only Difference is they added a label to it 🧬 1. (the actual drug) • What it is: The active ingredient (the molecule itself) • Class: Dual GIP + GLP-1 receptor Dosing for 7.5 Tirzepatide :

doi: 10.1111/dom.14944 31 JensterleMFerjanSVovkABattelinoTRizzoMJaneA

Thats a good thingbecause despite all the changes in this landscape, the demand for effective, affordable medications that help with weight loss and improve overall health isnt going anywhere

AOD-9604 is a targeted peptide that enhances fat metabolism by stimulating lipolysis and inhibiting lipogenesis

Other significant considerations include: Injection site reactions (for subcutaneous formulations) Hypoglycaemia risk (particularly if used alongside other glucose-lowering medications) Pancreatitis (rare but serious) Gallbladder disease (including gallstones and cholecystitis) Dehydration leading to acute kidney injury (particularly with severe gastrointestinal side effects) Diabetic retinopathy complications (particularly noted with semaglutide in diabetes patients) Potential thyroid effects (medullary thyroid carcinoma risk in animal studies, though human relevance remains unclear) A Parkinson's-specific concern is that GLP-1 receptor agonists delay gastric emptying, which may further impair levodopa absorption and potentially worsen motor fluctuations or 'OFF' periods in patients on this medication